New York-based research firm Market.US expects that the international electronic nose market will observe 18.5 per cent compound annual growth for the next nine years.
In a report published this month, the company explained that the market was currently worth US$44 billion and would ascend to US$101.2 billion by 2034.
This assessment is relatively similar to another made by Indian market analyst Precedence Research. The Pune-based firm said in May that it was valued at US$45.2 billion in 2025 and would hit US$132.6 billion within the next 10 years.
However, these numbers are questionably high. Mordor Intelligence, an India-based research analyst with a stronger track record than Market.US and Precedence, said in a September analysis that the sector would only be valued at US$282.8 million by 2030 — thereby throwing the other inflated predictions into question.
When considering the number of companies developing e-nose technologies and their size, the US$100+ billion figures hardly seem believable.
Nonetheless, the sector has unarguably been attracting an increasing rate of attention among investors and companies.
“The electronic nose market is gaining strong global attention as businesses look for advanced solutions to monitor and analyze odors and volatile organic compounds,” Market.US stated.
“These intelligent sensing devices, inspired by the human sense of smell, are creating a shift in quality control, environmental monitoring, and healthcare diagnostics.”
North America and the food and beverage industry dominate the market, Market.US has highlighted, accounting for 32.7 per cent of the market share and 32.6 per cent of total demand respectively.
Read more: Breath Diagnostics leader speaks at lung cancer education event in Louisville
Healthcare sector sees rapid e-nose adoption
The firm has pointed out that rapid advancements in AI-powered sensor technology and the non-invasive nature of e-nose devices for healthcare applications has been a significant catalyst.
Owlstone Medical — a key market player mentioned in the report that has developed a breath analytics tool for liver disease, lung cancer and other indications — currently competes with other innovators in the field. One of them, Kentucky-based Breath Diagnostics, has been overcoming the challenges traditionally associated with breath analysis technology. This company has developed a highly accurate lung cancer screening device that has been thoroughly assessed in multiple clinical studies.
Meanwhile, in the food industry, key players listed in the assessment like Alpha MOS and Aryballe Technologies use electronic nose tech to detect contamination, spoilage and implement quality control measures in a timely manner.
Electronic-nose air examination tools are being increasingly utilized for everything from identifying different varieties of coffee to bacteria detection, lung cancer testing and identifying gases present in the air.
Read more: Breath Diagnostics now offering a compelling investment opportunity
Follow Rowan Dunne on LinkedIn
rowan@mugglehead.com
